Clinical Trial Update: Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary? [NA]

View source ↗

Summary

A University of Vienna study recruiting to assess whether changing the needle in EBUS-TBNA improves discrimination of N2a vs N2b in lung cancer diagnosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: University of Vienna | Conditions: Lung Cancer (Diagnosis) | NA | Status: RECRUITING